Skip to contentV
Vsee Health, Inc.
V
VSEEWVsee Health, Inc. Q1 2025 · 10-Q
Revenue$3.32M$3.32M+104.9% vs Q1 2024 Net Income-$3.96M-$3.96MN/M vs Q1 2024 EPS Diluted-$0.24-$0.24N/M vs Q1 2024 Gross Profit$1,859,971+50.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vsee Health, Inc. · CIK 1864531 · Engraved from SEC EDGAR
Operating Cash Flow-$440,493N/M Free Cash Flowderived-$452,366N/M Margins · derivedGross margin56.0%−20.2 pt vs Q1 2024
Operating margin-55.1%−61.6 pt vs Q1 2024
Net margin-119.2%−123.1 pt vs Q1 2024
ended Mar 31, 2025 · filed Oct 15, 2025 · 198 d after period end